Diagnostic performance and prognostic value of circulating tumor DNA methylation marker in extranodal natural killer/T cell lymphoma-Reference-Cited by-同舟云学术

Diagnostic performance and prognostic value of circulating tumor DNA methylation marker in extranodal natural killer/T cell lymphoma

Published:2023-02 Issue:2 Volume:4 Page:100859
ISSN:2666-3791
Container-title:Cell Reports Medicine
language:en
Short-container-title:Cell Reports Medicine

Author:

Tian Xiao-Peng,Zhang Yu-Chen,Lin Ning-Jing,Wang Liang,Li Zhi-Hua,Guo Han-Guo,Ma Shu-Yun,An Ming-Jie,Yang Jing,Hong Yu-Heng,Wang Xian-Huo,Zhou Hui,Li Ya-Jun,Rao Hui-Lan,Li Mei,Hu Shao-Xuan,Lin Tong-Yu,Li Zhi-Ming,Huang He,Liang Yang,Xia Zhong-Jun,Lv Yue,Liu Yu-Ying,Duan Zhao-Hui,Chen Qing-Yu,Wang Jin-Ni,Cai Jun,Xie Ying,Ong Choon-Kiat,Liu Fang,Liu Yan-yan,Yan Zheng,Huang Liang,Tao Rong,Li Wen-Yu,Huang Hui-Qiang,Cai Qing-Qing

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference49 articles.

1. Extranodal natural killer/T-cell lymphoma, nasal type: Basic science and clinical progress;Harabuchi;Front. Pediatr.,2019

2. Natural killer-cell malignancies: diagnosis and treatment;Kwong;Leukemia,2005

3. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, Revised;Swerdlow,2017

4. The diagnosis and management of NK/T-cell lymphomas;Tse;J. Hematol. Oncol.,2017

5. Management of NK/T-Cell lymphoma, nasal type;Allen;J. Oncol. Pract.,2019

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Minimal residual disease detection in lymphoma: methods, procedures and clinical significance;Frontiers in Immunology;2024-08-12

2. Prospects for liquid biopsy approaches in lymphomas;Leukemia & Lymphoma;2024-08-10

3. First-line sintilimab with pegaspargase, gemcitabine, and oxaliplatin in advanced extranodal natural killer/T cell lymphoma (SPIRIT): a multicentre, single-arm, phase 2 trial;The Lancet Haematology;2024-05

4. The implication of next-generation sequencing in the diagnosis and clinical management of non-Hodgkin lymphomas;Frontiers in Oncology;2023-11-08

5. Circulating tumor DNA in NK/T and peripheral T cell lymphoma;Seminars in Hematology;2023-07